Esophageal Squamous Cell Carcinoma
📧 Sign up to get email alerts when something new happens for Esophageal Squamous Cell Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-07-20Clinical Trial Update: CT and Endoscopic Biopsy Image-Based Deep Learning for Predicting Left Recurrent Laryngeal Nerve Lymph Node Metastasis in Esophageal Cancer
The document reports a clinical trial using CT and endoscopic biopsy image-based deep learning to predict left recurrent laryngeal nerve lym…
-
CLINICAL_TRIALS research · 2025-07-11Clinical Trial Update: Predicting Early Tumor Recurrence in Patients With Esophageal Squamous Cell Carcinoma
A City of Hope Medical Center-sponsored clinical trial is recruiting to develop methods for predicting early tumor recurrence in patients wi…
-
CLINICAL_TRIALS research · 2025-07-11Clinical Trial Update: Predicting Postoperative Chemotherapy Efficacy in Patients With Esophageal Squamous Cell Carcinoma
A recruiting clinical trial aims to predict the effectiveness of postoperative chemotherapy in patients with esophageal squamous cell carcin…
-
CLINICAL_TRIALS research · 2025-07-08Clinical Trial Update: Patient Derived Organoids (PDOs) to Observe the Clinical Consistency of Personalized Neoadjuvant Therapy for Resectable Esophageal Squamous Cell Carcinoma
Clinical trial evaluating patient-derived organoids to observe the clinical consistency of personalized neoadjuvant therapy for resectable e…
-
CLINICAL_TRIALS research · 2025-07-03Clinical Trial Update: Lymph Node Metastasis in Early Esophageal Squamous Cell Carcinoma
A clinical trial studying early esophageal squamous cell carcinoma with lymph node metastasis is currently in recruitment, utilizing radiomi…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-06-26Clinical Trial Update: Cardenilimab Combined With Chemotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma [Phase 2]
A Phase 2 clinical trial evaluating cardenilimab in combination with chemotherapy for locally advanced esophageal squamous cell carcinoma is…
-
CLINICAL_TRIALS research · 2025-06-24Clinical Trial Update: Definitive Proton Radiotherapy Combined With Chemotherapy and Immunotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma: A Phase I Clinical Study [Phase 1]
Phase I study evaluating definitive proton radiotherapy combined with chemotherapy and immunotherapy for locally advanced esophageal squamou…
-
CLINICAL_TRIALS research · 2025-06-13Clinical Trial Update: Study on Adjuvant Chemotherapy After Total Two-field Lymph Node Dissection of Thoracic Esophageal Squamous Cell Carcinoma [NA]
This clinical trial update notes that a study evaluating adjuvant chemotherapy after total two-field lymph node dissection for thoracic esop…
-
CLINICAL_TRIALS research · 2025-06-12Clinical Trial Update: Immunochemotherapy ± Salvage Chemoradiation for Local Recurrence of Esophageal Squamous Cell Carcinoma After Definitive Chemoradiotherapy [Phase 3]
A Phase 3 clinical trial is evaluating immunochemotherapy with or without salvage chemoradiation for local recurrence of Esophageal Squamous…
-
CLINICAL_TRIALS research · 2025-06-12Clinical Trial Update: PD-1 Inhibitor Combined With Neoadjuvant Chemoradiotherapy Plus Surgery for Locally Advanced ESCC (NEOCRTEC2101) [Phase 3]
Phase 3 trial evaluating a PD-1 inhibitor in combination with neoadjuvant chemoradiotherapy and surgery for locally advanced esophageal squa…
-
CLINICAL_TRIALS research · 2025-06-12Clinical Trial Update: Neoadjuvant Radiochemotherapy Combined With Cadonilizumab for Local Advanced Esophageal Squamous Cell Cancer [Phase 2]
A Phase 2 trial investigating neoadjuvant radiochemotherapy combined with cadonilizumab for locally advanced esophageal squamous cell carcin…
-
CLINICAL_TRIALS research · 2025-06-06Clinical Trial Update: Low-dose Radiation Combined With Neoadjuvant Immunochemotherapy for Esophageal Squamous Cell Carcinoma [Phase 2]
Phase 2 trial evaluating the combination of low-dose radiation with neoadjuvant immunochemotherapy for esophageal squamous cell carcinoma is…
-
CLINICAL_TRIALS research · 2025-06-03Clinical Trial Update: Immunotherapy Combined With Chemoradiotherapy for First-line Treatment of Esophageal Squamous Cell Carcinoma（ChinECR） [NA]
A ChinECR study is evaluating immunotherapy combined with chemoradiotherapy as first-line treatment for esophageal squamous cell carcinoma. …
-
CLINICAL_TRIALS research · 2025-05-25Clinical Trial Update: Nimotuzumab Plus Definite Chemoradiotherapy(dCRT) in Elderly Patients With Esophageal Squamous Cell Carcinoma [Phase 2]
Phase 2 clinical trial evaluating nimotuzumab added to definitive chemoradiotherapy in elderly patients with esophageal squamous cell carcin…
-
CLINICAL_TRIALS research · 2025-05-22Clinical Trial Update: A Randomized Controlled Trial Evaluating of Prophylactic Irradiation in CRT for cT1bN0M0 ESCC [Phase 3]
A Phase 3 randomized trial in Japan is assessing prophylactic irradiation added to chemoradiotherapy for patients with cT1bN0M0 esophageal s…
-
CLINICAL_TRIALS research · 2025-05-22Clinical Trial Update: Diagnostic Accuracy of Endocytoscopy for Superficial Esophageal Neoplasia
A clinical trial update shows an ongoing study evaluating the diagnostic accuracy of endocytoscopy for superficial esophageal neoplasia, enr…
-
CLINICAL_TRIALS research · 2025-05-20Clinical Trial Update: SLND Versus Non-Dissection Following ESD for T1a Stage Esophageal Squamous Cell Carcinoma [NA]
Clinical trial comparing sentinel lymph node dissection versus no dissection after endoscopic submucosal dissection for T1a stage esophageal…
-
CLINICAL_TRIALS research · 2025-05-15Clinical Trial Update: Carrelizumab, Chemotherapy and Apatinib in the Neoadjuvant Treatment of Resectable Esophageal Squamous Cell Carcinoma [Phase 2]
Phase 2 trial update evaluating carrelizumab in combination with chemotherapy and apatinib as neoadjuvant treatment for resectable esophagea…
-
CLINICAL_TRIALS research · 2025-05-09Clinical Trial Update: Sequential Tegafur-gimeracil-oteracil Potassium Capsule (s-1) and Serplulimab Following Concurrent Chemoradiotherapy for Esophageal Squamous Cell Carcinoma [Phase 2]
Phase 2 trial assessing sequential S-1 chemotherapy followed by Serplulimab after concurrent chemoradiotherapy in locally advanced, inoperab…
-
CLINICAL_TRIALS research · 2025-05-02Clinical Trial Update: Volatile Organic Compounds as Breath Biomarkers in Squamous Oesophageal Neoplasms
Imperial College London is conducting a study to evaluate volatile organic compounds in breath as biomarkers for esophageal cancers. The tri…
-
CLINICAL_TRIALS research · 2025-04-18Clinical Trial Update: Neoadjuvant QL1706 Therapy for ESCC [Phase 2]
A Phase 2 neoadjuvant trial evaluating QL1706 for locally advanced resectable esophageal squamous cell carcinoma is currently recruiting.
-
CLINICAL_TRIALS research · 2025-04-17Clinical Trial Update: Benmelstobart Combined With Radiochemotherapy as Neoadjuvant Treatment Iin ESCC [Phase 2]
A Phase 2 clinical trial is evaluating Benmelstobart in combination with radiochemotherapy as neoadjuvant treatment for Esophageal squamous …
-
CLINICAL_TRIALS research · 2025-04-16Clinical Trial Update: A Phase II Study of Toripalimab Combined With Sequential Neoadjuvant Chemoradiotherapy in Patients With Esophageal Squamous Cell Carcinoma [Phase 2]
A Phase II clinical trial is evaluating Toripalimab with sequential neoadjuvant chemoradiotherapy for locally advanced esophageal squamous c…
-
CLINICAL_TRIALS research · 2025-04-02Clinical Trial Update: Optimizing Neoadjuvant Treatment Regimens for Locally Advanced Esophageal Squamous Cell Carcinoma [Phase 2, Phase 3]
Ongoing Phase 2/Phase 3 trial recruiting to optimize neoadjuvant regimens for locally advanced esophageal squamous cell carcinoma at Peking …
-
CLINICAL_TRIALS research · 2025-04-01Clinical Trial Update: Toripalimab Adjuvant Therapy in Subjects With Resected Esophageal Squamous Cell Carcinoma Who Achieved Pathological Complete Response (pCR) [Phase 2]
Phase 2 clinical trial evaluating adjuvant toripalimab after surgical resection for esophageal squamous cell carcinoma in patients achieving…